Spiral Therapeutics To Present At The Barany Society Meeting 2024
SOUTH SAN FRANCISCO, Calif., Aug. 21, 2024 — Spiral Therapeutics, Inc. (Spiral), a pharmaceutical company committed to developing advanced treatments for balance disorders and hearing loss, today announced that Dr. Jeffrey…
Read more
Spiral Therapeutics to Participate at the 2024 Wedbush PacGrow Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 5, 2024 — Spiral Therapeutics, Inc. (Spiral), a pharmaceutical company dedicated to developing advanced treatments for balance disorders and hearing loss, today announced that it will…
Read more
Spiral Therapeutics Announces CEO’s Participation at the 3rd Inner Ear Disorders Therapeutics Summit in Boston, MA
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, is proud to announce the participation of…
Read more
Spiral Therapeutics Announces SPT-2101 Presentation at the 15th ASOHNS Congress in Brisbane, Australia
SOUTH SAN FRANCISCO, Calif., Mar. 06, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced a presentation at the upcoming…
Read more
Spiral Therapeutics Announces Poster Presentation at Association for Research in Otolaryngology Annual Meeting
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced a presentation at the upcoming…
Read more
Spiral Therapeutics to Present at Biotech Showcase 2023
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced that the Company will provide…
Read more